The myelodysplasia treatment market is growing due to increasing prevalence of bone marrow disorders and hematological abnormalities. Advancements in drug therapies, supportive care, and early diagnosis are driving demand, with market expansion expected through 2028. https://www.databridgemarketresearch.com/reports/global-myelodysplasia-treatment-market